Ani Pharmaceuticals (ANIP) Notes Payables (2010 - 2011)

Ani Pharmaceuticals (ANIP) reported Notes Payables of $1.2 million for Q3 2011, up 3.92% sequentially from $1.2 million in Q2 2011.

Ani Pharmaceuticals (ANIP) Notes Payables (2010 - 2011) Analysis & Trends

Ani Pharmaceuticals (ANIP) has 2 years of Notes Payables data on file, last reported at $1.2 million in Q3 2011.

For the quarter ending Q3 2011, Notes Payables changed N/A year-over-year to $1.2 million; the trailing twelve-month figure through Sep 2011 stood at $1.2 million (changed N/A YoY), and the FY2010 full-year result was $1.1 million, changed N/A from the prior year.
Notes Payables climbed to $1.2 million in Q3 2011, from $1.2 million in the prior quarter.
In the past five years, Notes Payables ranged from a high of $1.2 million in Q3 2011 to a low of $1.1 million in Q4 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Ani Pharmaceuticals	1.64 Bn	1.33 Bn	143.88 Mn

Download Data